Market Pulse
Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Relmada Therapeutics expects to file IND for NDV-01 by year-end 2026, with Phase 3 RESCUE program initiation upon clearance.
Read full analysis →
Clean Energy Fuels reported $106.4 million in revenue for Q2 2026, up from $102.6 million in Q2 2025.
Read full analysis →
Yelp reported net revenue of $376 million for Q2 2026, exceeding its outlook by $8 million.
Read full analysis →
Zeta Global appointed Leah Pope as Chief Marketing Officer on August 3, 2026.
Read full analysis →
TriSalus Life Sciences reported Q2 2026 revenue of $11.4 million, up 1.7% year-over-year.
Read full analysis →
AEye's commercial pipeline reached a record high with 25 customers generating revenue, up 19% from Q1 2026.
Read full analysis →
Pulse Biosciences raised $46.8 million in Q2 2026 via ATM program, with an additional $10.7 million post-quarter.
Read full analysis →
Mach Natural Resources reported Q2 2026 net income of $98 million on revenue of $406 million.
Read full analysis →
Atlassian reported $1.8 billion in total revenue for Q4 2026, up 28% year-over-year.
Read full analysis →
Phase 3 enrollment for BIM-IOL System on track to complete in 2027, targeting ~1M annual cataract procedures.
Read full analysis →
RCI Hospitality reported $73.9M in total revenues for Q3 2026, up from $71.1M in the prior-year period.
Read full analysis →
Blend reported $33.8 million in revenue for Q2 2026, up 7% year-over-year.
Read full analysis →
Kopin Corporation (NASDAQ: KOPN) will participate in Canaccord Genuity's 46th Annual Growth Conference on August 11-13, 2026.
Read full analysis →
HASI reported Q2 2026 GAAP EPS of $0.92, up from $0.74 in Q2 2025.
Read full analysis →
OmniAb reported Q2 2026 revenue of $13.4M, up from $3.9M in the prior-year period, driven by milestone payments and increased service revenue.
Read full analysis →
Hyperfine reported Q2 2026 revenue of $3.9M, up 44.8% YoY.
Read full analysis →
Roku reported Q2 2026 financial results without an earnings call or outlook due to pending acquisition by Fox.
Read full analysis →
YCANTH dispensed applicator units grew 28.3% sequentially and 46.1% year-over-year to 19,626 in Q2 2026.
Read full analysis →
Guardian Pharmacy reported Q2 2026 revenue of $351.8 million, up 2% YoY.
Read full analysis →
$55 million revenue in Q2 2026, up 56% YoY and 12% sequentially.
Read full analysis →
